Sbir topic 255

Ended Definitive Contract Awarded Sep 30, 2009 Last action Nov 24, 2014

Contract number: HHSN261200900061C
Awardee: Myelorx LLC UEI ZWULNF1SNLR1
Awarding agency: National Cancer Institute National Institutes of Health, Department of Health and Human Services
Obligated: $1,917,332

Award facts

Opportunity: PHS20091 Solicitation number

Amend Description to Delete Requirements Award Notice · Posted Jul 17, 2008
Contract value 100% obligated: $1,917,332.00 Current and potential, with all options
Completion date 100% complete: Dec 12, 2013 Current and potential, with all options
NAICS code: 541711 Research and Development in Biotechnology
PSC: AN11 Health R&D Services; Health Care Services; Basic Research
Set-aside: Total Small Business
Competition: Full and Open Competition after exclusion of sources · 27 offers Negotiated Proposal / Quote
Pricing: Firm Fixed Price
Place of performance: Vallejo, CA 94592, USA
Research: SBIR Program Phase I Action

Award details come from SAM.gov/FPDS.

Transactions

Action	Obligated	Date
Other Administrative Action 7	$0	Nov 24, 2014
Other Administrative Action 6 · Phase II topic 255	$0	Dec 12, 2013
Other Administrative Action 5 · Phase II topic 255 (no cost extension through 12/31/2012)	$0	Mar 8, 2012
Exercise an Option 4 · Option period II, year 2, sbir topic 255 development of a triptolide derivative as a therapeutic agent	$740,277	Jan 5, 2011
Funding Only Action 3	$208,000	Sep 10, 2010
Exercise an Option 2 · Phase II topic 255	$789,607	Mar 19, 2010
Other Administrative Action 1	$0	Nov 10, 2009
Original award	$179,448	Sep 21, 2009

About this award

Written by GovTribe AI · Nov 24, 2024

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Myelorx LLC, a for-profit limited liability company. The contract has a total potential value of $1,917,332.00 and was awarded on September 30, 2009, with a period of performance ending on December 12, 2013. The contract is for research under SBIR Topic 255 and is designated as a total small business set-aside. No further details about the specific products or services being delivered under this contract were provided.

Quick answers

Who was awarded contract HHSN261200900061C?

HHSN261200900061C was awarded to Myelorx LLC by National Cancer Institute (National Institutes of Health) on September 30, 2009.

How much is contract HHSN261200900061C worth?

The government has obligated $1,917,332 on HHSN261200900061C.

Was contract HHSN261200900061C competed?

The extent of competition for HHSN261200900061C was full and open competition after exclusion of sources. The government received 27 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

Every transaction and funding action
The awardee's other awards and teaming partners
Similar awards and recompete opportunities
Ask GovTribe AI about this award

Try for free Login